Last update 21 Nov 2024

KSH-01

Overview

Basic Info

Drug Type
TCR therapy
Synonyms
Autologous CD4+/CD8+ T cells transduced with lentiviral vector directed against MAGE-A4 antigen
Target
MAGEA4
Mechanism
MAGEA4 inhibitors(Melanoma-associated antigen 4 inhibitors), Cell replacements
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
Relapsed Solid NeoplasmAdvanced Malignant Solid NeoplasmMelanoma
Inactive Indication-
Originator Organization
Keshihua (Nanjing) Biotechnology Co., Ltd.
Active Organization
Keshihua (Nanjing) Biotechnology Co., Ltd.
Inactive Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

Related

2
Clinical Trials associated with KSH-01
NCT05580796 / RecruitingEarly Phase 1
Investigator Initiated Clinical Trial on the Tolerance, Safety and Preliminary Efficacy of KSH01-TCRT Injection in Solid Tumor Subjects
NCT05539833 / RecruitingEarly Phase 1
A Single-arm, Prospective Clinical Study of KSH01-TCR-T in the Treatment of Refractory/Recurrent Solid Tumors
100 Clinical Results associated with KSH-01
Login to view more data
100 Translational Medicine associated with KSH-01
Login to view more data
100 Patents (Medical) associated with KSH-01
Login to view more data
1
Literatures (Medical) associated with KSH-01
01 Mar 2020International Journal of Biological Macromolecules
Structure, rheological, thermal and antioxidant properties of cell wall polysaccharides from Chinese quince fruits
100 Deals associated with KSH-01
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Relapsed Solid NeoplasmPhase 1
CN
Keshihua (Nanjing) Biotechnology Co., Ltd.
19 Aug 2022
Advanced Malignant Solid NeoplasmIND Approval
CN
Keshihua (Nanjing) Biotechnology Co., Ltd.
26 Apr 2024
MelanomaPreclinical
US
Keshihua (Nanjing) Biotechnology Co., Ltd.
23 Mar 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free